The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
Open accessAbstract
All ligands of the epidermal growth factor receptor (EGFR), which has important roles in development and disease, are released from the membrane by proteases. In several instances, ectodomain release is critical for activation of EGFR ligands, highlighting the importance of identifying EGFR ligand sheddases. Here, we uncovered the sheddases for six EGFR ligands using mouse embryonic cells lacking candidate-releasing enzymes (a disintegrin and metalloprotease [ADAM] 9, 10, 12, 15, 17, and 19). ADAM10 emerged as the main sheddase of EGF and betacellulin, and ADAM17 as the major convertase of epiregulin, transforming growth factor α, amphiregulin, and heparin-binding EGF-like growth factor in these cells. Analysis of adam9/12/15/17−/− knockout mice corroborated the essential role of adam17−/− in activating the EGFR in vivo. This comprehensive evaluation of EGFR ligand shedding in a defined experimental system demonstrates that ADAMs have critical roles in releasing all EGFR ligands tested here. Identification of EGFR ligand sheddases is a crucial step toward understanding the mechanism underlying ectodomain release, and has implications for designing novel inhibitors of EGFR-dependent tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974 · cited 2×
“The epidermal growth factor receptor (EGFR) signaling pathway has critical functions in development and in diseases such as cancer (Yarden and Sliwkowski, 2001).”
BackgroundInfluentialCohen, S. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83739-0 · Cited by 2,193
An Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607
Self-citationPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Growth factors from murine sarcoma virus-transformed cells.
de Larco, J. E., & Todaro, G. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.4001 · Cited by 1,461
Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype
Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C., et al. (1995) · Science · doi:10.1126/science.7618084 · Cited by 1,179
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., & Klagsbrun, M. (1991) · Science · doi:10.1126/science.1840698 · Cited by 1,127 · cited 4×
“…in this paper are synthesized as membrane-anchored precursors, and were initially identified as soluble biologically active growth factors (Cohen, 1962, 1965; de Larco and Todaro, 1978; Todaro et al., 1980; Shoyab et al., 1989; Higashiyama et al., 1991; Shing et al., 1993; Toyoda et al., 1995).”
BackgroundInfluentialSelf-citationThe ADAMs family of metalloproteases: multidomain proteins with multiple functions
Seals, D. F., & Courtneidge, S. A. (2003) · Genes & Development · doi:10.1101/gad.1039703 · Cited by 1,059
Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
Miettinen, P. J., Berger, J. E., Meneses, J., Phung, Y., Pedersen, R. A., Werb, Z., & Derynck, R. (1995) · Nature · doi:10.1038/376337a0 · Cited by 1,039
Strain-Dependent Epithelial Defects in Mice Lacking the EGF Receptor
Sibilia, M., & Wagner, E. F. (1995) · Science · doi:10.1126/science.7618085 · Cited by 1,002 · cited 3×
“Mice lacking ADAM17 die perinatally and resemble mice lacking TGF (Mann et al., 1993), HB-EGF (Iwamoto et al., 2003; Jackson et al., 2003), and the EGFR (Miettinen et al., 1995; Sibilia and Wagner, 1995; Threadgill et al., 1995; Peschon et al., 1998).”
BackgroundInfluential
Cited by
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
“Additional support for a crosstalk between PDGF and EGF signaling comes from studies of the ADAM17 protease, which releases active HB-EGF from its transmembrane precursor (Sahin et al., 2004).”
BackgroundMatrix metalloproteinases and the regulation of tissue remodelling
Page-McCaw, A., Ewald, A. J., & Werb, Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2125 · Cited by 2,630
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
EDWARDS, D., HANDSLEY, M., & PENNINGTON, C. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.001 · Cited by 1,161
ADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090
Self-citationMatrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
Roy, R., Yang, J., & Moses, M. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5556 · Cited by 854
Control of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703
Kuhn, P., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Roßner, S., & Lichtenthaler, S. F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.167 · Cited by 621
Rodríguez, D., Morrison, C. J., & Overall, C. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.015 · Cited by 560
Metalloproteinases and their natural inhibitors in inflammation and immunity
Khokha, R., Murthy, A., & Weiss, A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3499 · Cited by 552
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Ardito, C. M., Grüner, B. M., Takeuchi, K. K., Lubeseder-Martellato, C., Teichmann, N., Mazur, P. K., DelGiorno, K. E., Carpenter, E. S., Halbrook, C. J., Hall, J. C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.024 · Cited by 517
Neural regulation of lacrimal gland secretory processes: Relevance in dry eye diseases
Dartt, D. A. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.04.003 · Cited by 506
ADAM10 cleavage of N‐cadherin and regulation of cell–cell adhesion and β‐catenin nuclear signalling
Reiss, K., Maretzky, T., Ludwig, A., Tousseyn, T., de Strooper, B., Hartmann, D., & Saftig, P. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600548 · Cited by 481
Self-citationThe epidermal growth factor receptor ligands at a glance
Schneider, M. R., & Wolf, E. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21635 · Cited by 447
Shedding light on ADAM metalloproteinases
Huovila, A.-P. J., Turner, A. J., Pelto-Huikko, M., Kärkkäinen, I., & Ortiz, R. M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.006 · Cited by 453
Reiss, K., & Saftig, P. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.11.002 · Cited by 423
Self-citationEndothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
van Hinsbergh, V. W. M., & Koolwijk, P. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm102 · Cited by 420
Autocrine, paracrine and juxtacrine signaling by EGFR ligands
Singh, A. B., & Harris, R. C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.026 · Cited by 400
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378
“Metalloproteases of the ADAM (a disintegrin and metalloprotease) family are thought to be responsible for the shedding of certain EGFR ligands, with Adam10 emerging as the main sheddase of EGF (Sahin et al., 2004).”
Zhou, B.-B. S., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y., Baribaud, F., Mikami, I., Reguart, N., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.024 · Cited by 374
Role of the Epidermal Growth Factor Network in Ovarian Follicles
Conti, M., Hsieh, M., Park, J.-Y., & Su, Y.-Q. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0185 · Cited by 371
Gallic acid: Molecular rival of cancer
Verma, S., Singh, A., & Mishra, A. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.02.011 · Cited by 368
In search of partners: linking extracellular proteases to substrates
Overall, C. M., & Blobel, C. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2120 · Cited by 349
Self-citationAngiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
Lautrette, A., Li, S., Alili, R., Sunnarborg, S. W., Burtin, M., Lee, D. C., Friedlander, G., & Terzi, F. (2005) · Nature Medicine · doi:10.1038/nm1275 · Cited by 343
ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors
Ohtsu, H., Dempsey, P. J., & Eguchi, S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00620.2005 · Cited by 338
Neurogenesis and Alzheimer's disease: At the crossroads
Lazarov, O., & Marr, R. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.009 · Cited by 327
Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease
Chen, J., Zeng, F., Forrester, S. J., Eguchi, S., Zhang, M.-Z., & Harris, R. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00030.2015 · Cited by 327
Lichtenthaler, S. F., Lemberg, M. K., & Fluhrer, R. (2018) · The EMBO Journal · doi:10.15252/embj.201899456 · Cited by 323
Ojeda, S. R., Lomniczi, A., Mastronardi, C., Heger, S., Roth, C., Parent, A.-S., Matagne, V., & Mungenast, A. E. (2006) · Endocrinology · doi:10.1210/en.2005-1136 · Cited by 315
Horiuchi, K., Le Gall, S., Schulte, M., Yamaguchi, T., Reiss, K., Murphy, G., Toyama, Y., Hartmann, D., Saftig, P., & Blobel, C. P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-01-0014 · Cited by 310
Self-citationWunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., & Walter, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517540 · Cited by 296
Selective Use of ADAM10 and ADAM17 in Activation of Notch1 Signaling
Bozkulak, E. C., & Weinmaster, G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00406-09 · Cited by 309
Sternlicht, M. D., Sunnarborg, S. W., Kouros-Mehr, H., Yu, Y., Lee, D. C., & Werb, Z. (2005) · Development · doi:10.1242/dev.01966 · Cited by 309
Metalloproteinases and their inhibitors in tumor angiogenesis
Handsley, M. M., & Edwards, D. R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20945 · Cited by 307
Berasain, C., & Avila, M. A. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.01.005 · Cited by 304
Cancer invasion and metastasis: changing views
Duffy, M., McGowan, P., & Gallagher, W. (2008) · The Journal of Pathology · doi:10.1002/path.2282 · Cited by 302
Schulz, B., Pruessmeyer, J., Maretzky, T., Ludwig, A., Blobel, C. P., Saftig, P., & Reiss, K. (2008) · Circulation Research · doi:10.1161/circresaha.107.169805 · Cited by 301
Self-citationHoriuchi, K., Kimura, T., Miyamoto, T., Takaishi, H., Okada, Y., Toyama, Y., & Blobel, C. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2686 · Cited by 301
Self-citationSaftig, P., & Reiss, K. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.11.005 · Cited by 297
Self-citationNagano, O., Murakami, D., Hartmann, D., de Strooper, B., Saftig, P., Iwatsubo, T., Nakajima, M., Shinohara, M., & Saya, H. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200310024 · Cited by 294
Self-citationEGFR family: Structure physiology signalling and therapeutic targets †
Burgess, A. W. (2008) · Growth Factors · doi:10.1080/08977190802312844 · Cited by 288
Stratman, A. N., Schwindt, A. E., Malotte, K. M., & Davis, G. E. (2010) · Blood · doi:10.1182/blood-2010-05-286872 · Cited by 289
Salivary gland branching morphogenesis
Patel, V. N., Rebustini, I. T., & Hoffman, M. P. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00088.x · Cited by 284
Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling
Loganathan, S. K., Schleicher, K., Malik, A., Quevedo, R., Langille, E., Teng, K., Oh, R. H., Rathod, B., Tsai, R., Samavarchi-Tehrani, P., et al. (2020) · Science · doi:10.1126/science.aax0902 · Cited by 283
Metalloproteases regulate T‐cell proliferation and effector function via LAG‐3
Li, N., Wang, Y., Forbes, K., Vignali, K. M., Heale, B. S., Saftig, P., Hartmann, D., Black, R. A., Rossi, J. J., Blobel, C. P., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601520 · Cited by 282
Self-citationThe epidermal growth factor network: role in oocyte growth, maturation and developmental competence
Richani, D., & Gilchrist, R. B. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx029 · Cited by 278
Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage
van Tetering, G., van Diest, P., Verlaan, I., van der Wall, E., Kopan, R., & Vooijs, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006775 · Cited by 274
Shiomi, T., Lemaître, V., D'Armiento, J., & Okada, Y. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02547.x · Cited by 274
Emerging roles of ADAM and ADAMTS metalloproteinases in cancer
Rocks, N., Paulissen, G., El Hour, M., Quesada, F., Crahay, C., Gueders, M., Foidart, J. M., Noel, A., & Cataldo, D. (2008) · Biochimie · doi:10.1016/j.biochi.2007.08.008 · Cited by 266
Ectodomain shedding and ADAMs in development
Weber, S., & Saftig, P. (2012) · Development · doi:10.1242/dev.076398 · Cited by 259
Self-citationRole of ADAMs in Cancer Formation and Progression
Duffy, M. J., McKiernan, E., O'Donovan, N., & McGowan, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1585 · Cited by 259
Xu, P., & Derynck, R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.034 · Cited by 257
Matrix metalloproteinases and epidermal wound repair
Martins, V. L., Caley, M., & O’Toole, E. A. (2013) · Cell and Tissue Research · doi:10.1007/s00441-012-1410-z · Cited by 253
Targeting TACE-dependent EGFR ligand shedding in breast cancer
Kenny, P. A., & Bissell, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29518 · Cited by 252
Franzke, C.-W., Cobzaru, C., Triantafyllopoulou, A., Löffek, S., Horiuchi, K., Threadgill, D. W., Kurz, T., van Rooijen, N., Bruckner-Tuderman, L., & Blobel, C. P. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112258 · Cited by 186
Self-citationADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk
Higashiyama, S., & Nanba, D. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.11.009 · Cited by 162
Self-citationRECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity
Muraguchi, T., Takegami, Y., Ohtsuka, T., Kitajima, S., Chandana, E. P. S., Omura, A., Miki, T., Takahashi, R., Matsumoto, N., Ludwig, A., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1922 · Cited by 149
Evans, S. F., Irmady, K., Ostrow, K., Kim, T., Nykjaer, A., Saftig, P., Blobel, C., & Hempstead, B. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219675 · Cited by 124
Self-citationZhong, S., & Khalil, R. A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.033 · Cited by 119
The ADAMs family: Coordinators of nervous system development, plasticity and repair
Yang, P., Baker, K. A., & Hagg, T. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.05.001 · Cited by 116
Kyula, J. N., Van Schaeybroeck, S., Doherty, J., Fenning, C. S., Longley, D. B., & Johnston, P. G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0014 · Cited by 99
Johnson, N., Březinová, J., Stephens, E., Burbridge, E., Freeman, M., Adrain, C., & Strisovsky, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-07556-3 · Cited by 54
Muliyil, S., Levet, C., Düsterhöft, S., Dulloo, I., Cowley, S. A., & Freeman, M. (2020) · The EMBO Journal · doi:10.15252/embj.2020104415 · Cited by 36
Siney, E. J., Holden, A., Casselden, E., Bulstrode, H., Thomas, G. J., & Willaime-Morawek, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0053-6 · Cited by 35
“As ADAM10 and ADAM17 are overexpressed in glioblastoma where they can act to increase the EGF concentration in the niche then anti-ADAM10 and ADAM17 treatment may mediate migration out of the niche by reducing local EGF concentrations.”
InfluentialJones, A. V., Lambert, D. W., Speight, P. M., & Whawell, S. A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.09.010 · Cited by 35
Molecular basis for the mechanism of action of an anti‐TACE antibody
Peng, L., Cook, K., Xu, L., Cheng, L., Damschroder, M., Gao, C., Wu, H., & Dall'Acqua, W. F. (2016) · mAbs · doi:10.1080/19420862.2016.1226716 · Cited by 30
Lin, C.-W., Yang, W.-E., Su, C.-W., Lu, H.-J., Su, S.-C., & Yang, S.-F. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91786 · Cited by 24
“It is known that proteolytical cleavage by a disintegrin and a metalloprotease 17 (ADAM17) released soluble forms of EREG to bind and activate ERBB1/EGFR and ERBB4/Her4, ultimately functioning as a driver of metastasis [46, 47].”
BackgroundKahveci-Türköz, S., Bläsius, K., Wozniak, J., Rinkens, C., Seifert, A., Kasparek, P., Ohm, H., Oltzen, S., Nieszporek, M., Schwarz, N., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04783-y · Cited by 17
Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence.
Morancho, B., Martínez-Barriocanal, Á., Villanueva, J., & Arribas, J. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0619-7 · Cited by 13
“ADAM17 cleaves Areg [18], APP [19], DDR1 [20], EphB4 [21], Met [22], and EpCAM [23].”
BackgroundJoseph, B. B., Edeen, P. T., Meadows, S., Binti, S., & Fay, D. S. (2022) · PLOS Genetics · doi:10.1371/journal.pgen.1010249 · Cited by 13
Rose, C., Dorard, E., Audrain, M., Gorisse-Hussonnois, L., Cartier, N., Braudeau, J., & Allinquant, B. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.008 · Cited by 12
Bläsius, K., Ludwig, L., Knapp, S., Flaßhove, C., Sonnabend, F., Keller, D., Tacken, N., Gao, X., Kahveci-Türköz, S., Grannemann, C., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05132-3 · Cited by 12
Christensen, S. K., Narimatsu, Y., Simoes, S., Goth, C. K., Vægter, C. B., Small, S. A., Clausen, H., & Andersen, O. M. (2020) · doi:10.1101/2020.07.12.199885 · Cited by 11
Metadata
- Authors
- Sahin, U., Weskamp, G., Kelly, K., Zhou, H.-M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P., & Blobel, C. P.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2004-03-01
- Volume
- 164
- Issue
- 5
- Pages
- 769-779
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2072219853
- Cited by
- 979
- References
- 58
- FWCI
- 22.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.